Indrayani Biotech’s arm to invest in Kniss Laboratories

14 Apr 2023 Evaluate

Indrayani Biotech’s wholly owned subsidiary -- M/s IBL Healthcare is planning to invest in M/s Kniss Laboratories by subscribing to the company's proposed issuance of Compulsory Convertible Debentures (CCDs). Kniss Laboratories is a pharma manufacturing unit certified by ISO 9001-2008 for quality compliance and awarded good manufacturing practice license by state drug authority of India.

Indrayani Biotech is a company belonging to food sector. They are a part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. It plans to produce these seeds for Hoechst in due course of time.

Indrayani Biotech Share Price

42.37 0.27 (0.64%)
14-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Indrayani Biotech 42.37
SIP Industries 6.01
Trescon 15.90
Jayasilpa Floritech
Farmtek Agro Exports
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.